A Study of the Gene Make-up of Heart Tumors


About this study

The purpose of this study is to help identify the biology of heart tumors and understand how and why they form.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

 Inclusion Criteria

  • Patients must have a cardiac tumor that is clinically, radiologically or pathologically suspicious for cardiac myxoma
  • Patient is a good medical candidate for a standard of care surgical procedure to resect the tumor and undergo a routine blood draw
  • Patient is ≥18 years of age
  • Patient is willing to undergo session(s) with a genetic counselor (GC) to discuss results, should they be relevant to their medical care
  • Patients must understand and provide written informed consent and HIPAA authorization prior to initiation of any study-specific procedures.


Exclusion Criteria

  • Patients with conditions that would limit compliance with the study requirements or the ability to provide, willingly, written informed consent
  • Women who are pregnant at the time of surgical resection of the cardiac tumor

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Joseph Maleszewski, M.D.

Open for enrollment

Contact information:

Joseph Maleszewski M.D.



More information


Publications are currently not available

Mayo Clinic Footer